Deepak Dsouza
Psychiatry · West-Haven, CTNPI 1821172073
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $1,550 of the $1,550 with a category attached, or 100.0%. Jazz Pharmaceuticals Inc. accounts for 67.7% of it on its own, with 1 other manufacturer making up the rest.
Across 2 payments — averaging $775.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$1K
- Biohaven Pharmaceutical Holding Company Ltd.$500
Across 125 payments — averaging $9139.69 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boehringer Ingelheim$458K
- Jazz Pharmaceuticals Inc.$286K
- Biogen$130K
- Takeda Pharmaceuticals U.S.A., Inc.$126K
- AbbVie$104K
- Merck$33K
- plus $6K from 2 others
What the payments were for
- Consulting fees$1,550100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 1 | $1,050 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $500 |
How this compares
$1,550 in reported general payments places this provider in the 80th percentile of 644 psychiatry providers in Connecticut.
Other psychiatry in West-Haven
- Vladimir CoricNew Haven$133.7M
- Donald AmmermanDanbury$1.5M
- Joseph GoldbergNew Canaan$914K
- Lisa HardingMilford$608K
- Tarique PereraDanbury$383K
- John GelinasDanbury$364K
- Irene AbramovichWest Hartford$352K
- Robert BermanNew Haven$126K
- John KrystalWest Haven$122K
- David MatuskeyFarmington$120K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.